FindTrial
Sign In

Observational Study of Dhatupak Lakshan in Madhumeha (Type II Diabetis Mellitus) with Special Reference to HbA1c Glycosylated Heamoglobin.

Observational Study of Dhatupak Lakshanas in Madhumeha (Type II DM)with Special Reference to HbA1c. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065338
Enrollment
150
Registered
2024-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs Health Condition 2: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Sponsors

Dr Pranali SBhende Kanakdande
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with known case of Diabetes Mellitus Type II with HB1AC greater than 8 percent

Exclusion criteria

Exclusion criteria: Patients with HB1AC below 8 percent

Design outcomes

Primary

MeasureTime frame
To study Dhatupak lakshan in raised HB1AC in Madhumeha (Type II DM) Timepoint: one time observation with follow up of 1month—

Secondary

MeasureTime frame
To study association between Dhatupak lakshan in raised HB1AC in Madhumeha (Type II DM) Timepoint: 1 month will be assessed—

Countries

India

Contacts

Public ContactDr.Pranali S Bhende (Kanakdande)

DMM AYURVED MAHAVIDYALAYA YAVATMAL

rajivmundane19@gmail.com9850719571

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026